News | April 23, 2026
AbbVie bets $1.4B on North Carolina pharma mega-campus
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
Move comes amid rising regulatory pressures
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
Subscribe To Our Newsletter & Stay Updated
